billy.pilgrim wrote: Wed Dec 27, 2017 2:21 pmSo why didn't Obama when he had both houses?
Obama only ever had a clear majority in both houses. He needed a filibuster-proof Senate supermajority to get legislation passed, and he never had that.
Also, I don't remember their specific positions on letting Medicare negotiate drug prices, but "Dem." Senators Nelson, Baucus and Lieberman were rotten on other liberal healthcare aims like the public option and definitely single payer. So, whichever one of you is correct even 60 would have never meant 60.
The Truth Will Set You Free, But First It Will Piss You Off
-- Gloria Steinem
1312. ETTD. 86 47.
billy.pilgrim wrote: Wed Dec 27, 2017 2:21 pmSo why didn't Obama when he had both houses?
Obama only ever had a clear majority in both houses. He needed a filibuster-proof Senate supermajority to get legislation passed, and he never had that.
Also, I don't remember their specific positions on letting Medicare negotiate drug prices, but "Dem." Senators Nelson, Baucus and Lieberman were rotten on other liberal healthcare aims like the public option and definitely single payer. So, whichever one of you is correct even 60 would have never meant 60.
Filibuster hasn't done much to stop trump and the repugs. Obama just quit trying to sell the public on anything after the election. It was amazing to watch loser Palin keep beating him up over imaginary Death Panels.
Trump: “We had the safest border in the history of our country - or at least recorded history. I guess maybe a thousand years ago it was even better.”
billy.pilgrim wrote: Wed Dec 27, 2017 2:21 pm
So why didn't Obama when he had both houses?
Obama only ever had a clear majority in both houses. He needed a filibuster-proof Senate supermajority to get legislation passed, and he never had that.
So if no repub Senator voted for the ACA how did it pass?
... On December 23, the Senate voted 60–39 to end debate on the bill: a cloture vote to end the filibuster. The bill then passed, also 60–39, on December 24, 2009, with all Democrats and two independents voting for it, and all Republicans against (except Jim Bunning, who did not vote). The bill was endorsed by the AMA and AARP.
On January 19, 2010, Massachusetts Republican Scott Brown was elected to the Senate in a special election to replace Kennedy, having campaigned on giving the Republican minority the 41st vote needed to sustain Republican filibusters....
rstrong's link is "Debunking the Myth: Obama's Two-Year Supermajority", but I think you're correct that there was a theoretical (Nelson, Baucus and Lieberman ) supermajority for about four months. "Kirk was appointed as Senator Kennedy's temporary replacement on September 24."
billy.pilgrim wrote: Wed Jan 31, 2018 7:44 pmFilibuster hasn't done much to stop trump and the repugs....
They've changed the rules such that filibusters can't be used as often. Strangely, it only takes a simple majority to do that. The GOP has decided that raw power now is worth the risk of getting a taste of their own medicine when the Dems have the Senate and WH again.
The Truth Will Set You Free, But First It Will Piss You Off
-- Gloria Steinem
1312. ETTD. 86 47.
billy.pilgrim wrote: Wed Jan 31, 2018 7:44 pmFilibuster hasn't done much to stop trump and the repugs....
They've changed the rules such that filibusters can't be used as often. Strangely, it only takes a simple majority to do that. The GOP has decided that raw power now is worth the risk of getting a taste of their own medicine when the Dems have the Senate and WH again.
So, what's the plan for 2020, elect another wall street tax cutter for the rich who can't even find time to go to the American public with something to stop our insane wealth giveaway to the drug companies, or will we use our majority in 2018 to change the rules back so the repugs can filibuster?
Trump: “We had the safest border in the history of our country - or at least recorded history. I guess maybe a thousand years ago it was even better.”
billy.pilgrim wrote: Thu Feb 01, 2018 9:53 amSo, what's the plan for 2020, elect another wall street tax cutter for the rich who can't even find time to go to the American public with something to stop our insane wealth giveaway to the drug companies,
There's a pretty good chance that will describe the candidates from both parties.
or will we use our majority in 2018 to change the rules back so the repugs can filibuster?
Doesn't really matter since the GOP will still have the WH veto. However, the Dem filibuster rules will matter in 2021 if it then holds both the WH and Senate.
The Truth Will Set You Free, But First It Will Piss You Off
-- Gloria Steinem
1312. ETTD. 86 47.
Vrede too wrote: Thu Feb 01, 2018 2:17 am
rstrong's link is "Debunking the Myth: Obama's Two-Year Supermajority", but I think you're correct that there was a theoretical (Nelson, Baucus and Lieberman ) supermajority for about four months.
Theoretical in the same sense Republicans were theoretically bipartisan and would never abuse the filibuster. There's a reason - actually several- that Joe Lieberman is known as the junior senator from Aetna.
rstrong wrote: Thu Feb 01, 2018 11:04 amTheoretical in the same sense Republicans were theoretically bipartisan and would never abuse the filibuster. There's a reason - actually several- that Joe Lieberman is known as the junior senator from Aetna.
IMO the biggest problems with the ACA are the compromises that were necessary to get the votes from the senators from Aetna. Bax Mucus has backtracked, not sure about the others. http://www.blueridgedebate.com/viewtopi ... cus#p79029
Or, you could say that the key problem that no one has tried to push SP during the Obama administration when he was so busy trying to please repugs and didn't have time to push the only program that made sense.
Trump: “We had the safest border in the history of our country - or at least recorded history. I guess maybe a thousand years ago it was even better.”
billy.pilgrim wrote: Thu Feb 01, 2018 12:12 pm
Or, you could say that the key problem that no one has tried to push SP during the Obama administration when he was so busy trying to please repugs and didn't have time to push the only program that made sense.
The senators from Aetna wouldn't even allow testimony on single payer. I regret that Obama didn't push harder on the public option, but I don't think there was ever hope for single payer.
The Truth Will Set You Free, But First It Will Piss You Off
-- Gloria Steinem
1312. ETTD. 86 47.
It's only once it was obvious that he'd never have the votes for single-payer that he adopted 15 years of Republican policy as the ACA. It was better than nothing, and even the Republicans wouldn't be hypocritical and dishonest enough to oppose it.
... Mission said this week its board of directors voted unanimously to execute a letter of intent to be acquired by HCA, a for-profit health company with 177 hospitals and 240,000 employees across 20 states and the United Kingdom. If the deal meets acceptable terms and receives regulatory approval, it would be HCA's first entry into North Carolina....
:cussing: This is a betrayal of Asheville and all of the nonprofit hospitals that were absorbed by Mission Health and their communities.
The Truth Will Set You Free, But First It Will Piss You Off
-- Gloria Steinem
1312. ETTD. 86 47.
"The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies," analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow."
Trump: “We had the safest border in the history of our country - or at least recorded history. I guess maybe a thousand years ago it was even better.”
"The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies," analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow."
Read something more from this piece of shit
about this same Goldman Sachs sustainable business model,
“In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients. …”